Download PDF
SARcode Bioscience, Inc., is a privately held, venture-backed biopharmaceutical company based in Brisbane, CA.

SARcode Bioscience is developing novel molecules that specifically target chronic T-cell mediated inflammation in ophthalmic and dermatologic disease.
SAR 1118 mechanism of action
September 14, 2011

First Patient Enrolled in SARcode Bioscience's Pivotal Dry Eye Study of SAR 1118 Ophthalmic Solution